15:43 EDT MoonLake Immunotherapeutics jumps 8% after report of exploring sale
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on MLTX:
- MoonLake price target raised to $65 from $29 at Cantor Fitzgerald
- MoonLake Immunotherapeutics 8M share Secondary priced at $50.00
- MoonLake Immunotherapeutics Announces Pricing of $400 Million Upsized Public Offering of Class A Ordinary Shares
- MoonLake Immunotherapeutics price target raised to $61 from $33 at Wedbush
- MoonLake Immunotherapeutics price target raised to $68 from $36 at BTIG